The New Torrent
The 'pharmaceutical to power' group has kickstarted a makeover plan with focus on renewable and diversification into health.
ranbaxy
November 2024
September 2022
September 2018
January 2011
Shanghvi's Silent 'Sun' Rise
Acquisitions and product focus make Shanghvi India's wealthiest drug maker.
Shivinder drags brother Malvinder to NCLT
Former Ranbaxy promoter dissociates with brother; case also names former Religare chief Godhwani.
Daiichi overhauls Ranbaxy
The Indianness of the homegrown pharma major is slowly but surely being diluted by its new Japanese owners. Not without its fair share of obstacles, though.
